Gregory Gerstner, Seigfreid Bingham

Autor: Staff Report

Publikováno v: Missouri Lawyers Media. 09/12/2024.

360 A phase 1 study of an Off-the-Shelf, multi-neoantigen vector (ADXS-503) alone and in combination with pembrolizumab in subjects with metastatic non-small cell lung cancer (NSCLC)

Autor: Suresh Ramalingam, Jonathan Goldman, Thomas Stinchcombe, Gregory Gerstner, Missak Haigentz, Surya Vangala, Megan Parsi, Victor Kabala, Dinesh Simkhada, Andres Gutierrez

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

Externí odkaz: https://doaj.org/article/3c83edd4098443779669a783f3e8302a

Decreased Bone Mineral Density among Patients with Hemophilia

Autor: Wendy Schultz, Michael Recht, Alison Stopeck, Christina Worman, Gregory Gerstner, Mary Lou Damiano, Angela Tom

Publikováno v: Blood. 110:1153-1153

Background: Osteoporosis among adult males is a major and under-recognized problem in the United States. Patients with hemophilia have several predisposing risks for developing decreased bone mineral density (BMD) and osteoporosis, and may represent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a25eecbb1e701efaea91e0ec32ba5971
https://doi.org/10.1182/blood.v110.11.1153.1153

Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.

Autor: Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de., Dziadziuszko R; Faculty of Medicine, Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Kao S; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Hochmair M; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna North Hospital Klinik Floridsdorf, Vienna, Austria., Huemer F; Department of Respiratory Care, Ludwig Boltzmann Institute for Lung Health, Klinik Penzing, Vienna, Austria., de Castro G Jr; Clinical Oncology, Instituto de Cancer do Estado de São Paulo, Hospital Das Clínicas Da FMUSP, São Paulo, Brazil., Havel L; First Faculty of Medicine, Charles University, Thomayer Hospital, Prague, Czech Republic., Bernabé Caro R; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Losonczy G; Faculty of Medicine, Semmelweis University, Budapest, Hungary., Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea., Kowalski DM; Department of Lung Cancer and Chest Tumours, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Andric Z; Department of Medical Oncology, Clinical Hospital Centre Bezanijska Kosa, Belgrade, Serbia., Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK., Veatch A; Northwest Medical Specialties, Puyallup, WA, USA., Gerstner G; Illinois Cancer Care, Peoria, IL, USA., Batus M; Medical Oncology, Rush University Medical Center, Chicago, IL, USA., Morris S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kaul M; Oncology Product Development Safety, Genentech Inc, South San Francisco, CA, USA., Cuchelkar V; Product Development Oncology-Hematology, Genentech, South San Francisco, CA, USA., Li H; Roche, Product Development China, Shanghai, China., Danner BJ; Genentech, South San Francisco, CA, USA., Nabet BY; Computational Sciences, Genentech, South San Francisco, CA, USA., Liu SV; Thoracic Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Oct; Vol. 196, pp. 107924. Date of Electronic Publication: 2024 Aug 10.